Fundamental Analysis in Trading: How Economic Indicators Shape Market Decisions – Insights from Octa Broker
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 9 March 2025 – In 2025, global markets are navigating a phase […]
Media OutReach
Media OutReach
Media OutReach
Shaping The Future: Celebrating Women In Technology This International Women’s Day
SINGAPORE – Media OutReach Newswire – 8 March 2025 – This International Women’s Day, with its powerful theme of “For
Octa broker receives the ‘Best use of AI in fintech’ award
KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 8 March 2025 – OctaTrader, Octa broker’s proprietary trading platform, was recently
Professor Daniela Rus: A new voice in the VinFuture Prize Council – Honoring AI and Robotics revolution
HANOI, VIETNAM – Media OutReach Newswire – 7 March 2025 – As Artificial Intelligence (AI) and robotics have increasingly reshaped
Watch Exchange Singapore Welcomes Jack Neo as Official Brand Ambassador
SINGAPORE – Media OutReach Newswire – 7 March 2025 – Watch Exchange proudly announces the appointment of renowned Singaporean filmmaker
Singapore’s Female Entrepreneurs Find Global Success on Amazon
SINGAPORE – Media OutReach Newswire – 7 March 2025 – Every year hundreds of entrepreneurs are launching their brands on
Media OutReach
Wildberries Identifies the Most Popular Gifts for International Women’s Day
MOSCOW, RUSSIA – Media OutReach Newswire – 7 March 2025 – Wildberries, a leading e-commerce platform in Eurasia, surveyed its
Media OutReach
Captiva Verde Announces Matnaggewinu Development Corp (MDC) Has Been Certified as an Indigenous Business by CCIB, Unlocking Federal Procurement Opportunities
Vancouver, British Columbia – Newsfile Corp. – March 6, 2025 – Captiva Verde Wellness Corp. (CSE: PWR) (OTC Pink: CPIVF)
Media OutReach
Gorilla Sets Record Straight on Baseless Market Speculation
London, United Kingdom – Newsfile Corp. – March 6, 2025 – Gorilla Technology Group Inc. (NASDAQ: GRRR) (“Gorilla” or the
Media OutReach
Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
The Interim Analysis Showed Complete Clinical Clearance of More than Sixty (60%) Percent Philadelphia, Pennsylvania – Newsfile Corp. – March
